Assessing the patient experience of respiratory syncytial virus infection: development of a patient-reported outcome measure
Abstract Background Respiratory syncytial virus (RSV) causes significant morbidity and mortality in older adults. Despite a number of RSV vaccine candidates in clinical trials, there are no existing disease-specific, self-reported measures that assess the symptoms and severity of RSV infection from...
Main Authors: | Carla (DeMuro) Romano, Lyn Finelli, Sandy Lewis, Valerie Williams, Emily Martin, Matthew Phillips, Todd L. Saretsky, Josephine Norquist |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-02-01
|
Series: | Health and Quality of Life Outcomes |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12955-022-02066-x |
Similar Items
-
Psychometric evaluation of the respiratory syncytial virus infection, intensity and impact questionnaire (RSV-iiiQ) in adults
by: Valerie Williams, et al.
Published: (2024-02-01) -
Epidemiology and prevention of respiratory syncytial virus infections in children in Italy
by: Chiara Azzari, et al.
Published: (2021-10-01) -
Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians
by: Matteo Riccò, et al.
Published: (2023-02-01) -
RSV disease in infants and young children: Can we see a brighter future?
by: Eugenio Baraldi, et al.
Published: (2022-11-01) -
Epidemiology and molecular characteristics of respiratory syncytial virus (RSV) among italian community-dwelling adults, 2021/22 season
by: Donatella Panatto, et al.
Published: (2023-03-01)